Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levemir versus NPH insulin in pregnant women with type 1 diabetes
2006-004861-33Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin detemir in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: HbA1c at gestational week 36. Started Jan 2007; status: completed.
02
Drugs
insulin detemir
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-004861-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004861-33.